logo

For the Inventor, By the Inventor

Richmond, CA, United States of America

Yuanxi Zhou

This inventor holds 40 USPTO granted patents and 4 published patent applications, primarily in Glycosidase Inhibitors. Top assignees: Alectos Therapeutics Inc., Merck Sharp + Dohme Corp., Anormed, Inc.. Active years: 2004-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuanxi Zhou. Retrieved from https://idiyas.com/inventor/yuanxi-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 

% Patents Active = 32.5

Average Co-Inventor Count = 8.1

ph-index = 9

Forward Citations = 266(Granted Patents)


Location History:

  • Langley, CA (2004 - 2005)
  • Surrey, CA (2006 - 2009)
  • British Columbia, CA (2017)
  • Burnaby, CA (2015 - 2018)
  • Richmond, CA (2010 - 2021)

Company Filing History:

goldMedal16 out of 19 
 
Alectos Therapeutics Inc.
 patents
silverMedal15 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal10 out of 40 
 
Anormed, Inc.
 patents
4. 8 out of 825 
 
Genzyme Corporation
 patents
5. 3 out of 8 
 
Zalicus Pharmaceuticals, Ltd.
 patents
6. 1 out of 157 
 
Simon Fraser University
 patents
7. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2021

Loading Chart...
Areas of Expertise:
Glycosidase Inhibitors
Chemokine Receptor Compounds
Glucocerebrosidase Modulators
Heterocyclic Compounds
Calcium Channel Blockers
Piperidine Derivatives
Selective Inhibitors
Enhanced Efficacy
Thiazolyl Acetamides
Substituted Piperidines
Binding Compounds
40 patents (USPTO):Explore Patents
1. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof (2021-02-09),
2. 10322111 - Chemokine receptor binding heterocyclic compounds with enhanced efficacy (2019-06-18),
3. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),
4. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),
5. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),
6. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),
7. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),
8. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),
9. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),
10. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),
11. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),
12. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),
13. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),
14. 9243020 - Selective glycosidase inhibitors and uses thereof (2016-01-26),
15. 9199949 - Selective glycosidase inhibitors and uses thereof (2015-12-01),

Title: Yuanxi Zhou: Pioneering Inventor from Richmond

Introduction: Yuanxi Zhou, a distinguished inventor hailing from Richmond, CA, has made significant contributions to the field of technology and innovation.

Latest Patents: Yuanxi Zhou holds several groundbreaking patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Yuanxi Zhou has worked with leading tech companies, research institutions, and universities, honing his skills and expertise in developing cutting-edge solutions to complex problems.

Collaborations: Throughout his career, Yuanxi Zhou has collaborated with top scientists, engineers, and fellow inventors, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: Yuanxi Zhou's passion for innovation, coupled with his relentless drive to push the boundaries of technology, solidifies his position as a trailblazing inventor in the ever-evolving landscape of invention and discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…